Building on the success of 2016’s “EMEA Corporate Liability Handbook,” we are pleased to present you with the first global edition that collates and describes in detail the corporate liability and corporate crime regimes of countries in Asia, EMEA and the Americas.
Amendment to China’s Anti-Unfair Competition Law increases risk of commercial bribery and imposes tougher...
On 4 November 2017, the PRC Anti-Unfair Competition Law was amended providing more clarity on the scope of what constitutes commercial bribery. This post provides an insight on the key features of the new commercial bribery rules.
The PRC Supreme People's Court and Supreme People's Procuratorate have recently issued the Interpretation of Various Issues Concerning Application of Law in Handling Crimes of Infringing upon Citizen's Personal Information.
The aim of this quarterly is to give you a regular, brief practical overview of significant competition law developments that may affect your business operations in the region.
The US Treasury Department’s Financial Crimes Enforcement Network issued for public inspection a notice of proposed rulemaking that would restrict a Chinese commercial bank’s access to the US financial system based on a finding that the bank was involved in money laundering activities involving North Korea.
We have summarized the results of the compliance studies of the past 12 months and summarized the results in this post. Find out how you measure up against the benchmark.
We are very pleased to present you the latest edition of our Global Overview of Anti-Bribery Laws Handbook, updated with detailed information about key legislative and enforcement activity in the anti-bribery and corruption sphere.
Tthe second-largest producer of telecommunications equipment in China, entered into a plea agreement with the US Department of Justice for violations of US sanctions against Iran and US export controls.
The China Food and Drug Administration has issued guidelines aimed to implement China's new Cybersecurity Law in the administration of medical devices in China. This development is a clear signal that Chinese regulators intend to enhance cybersecurity protection in the healthcare sector.
China has launched the “two-invoice” system in drug distribution on a trial basis, aiming to improve transparency in drug prices and eliminate excessive profit margins associated with multi-tier distribution models.